A comparative analysis of ACE Inhibitors and ARBs as cancer risk factors

• Belle Tamir Brahms ,

  Contributed equally to this work with: Belle Tamir Brahms, Shani Afek

  Roles Writing – original draft

  * E-mail: beltamir@gmail.com

  Affiliation Department of Family Medicine, Clalit Health Services, Sharon-Shomron, Israel

  https://orcid.org/0009-0008-4665-6837

  ⨯
• Shani Afek ,

  Contributed equally to this work with: Belle Tamir Brahms, Shani Afek

  Roles Writing – original draft

  Affiliations Department of Family Medicine, Clalit Health Services, Sharon-Shomron, Israel, Dina Recanati School of Medicine, Reichman University, Herzliya, Israel

  ⨯
• Michael Hopp,

  Roles Formal analysis

  Affiliation Omnistat & Tel Aviv University, Tel Aviv, Israel

  ⨯
• Martine Granek-Catarivas,

  Roles Supervision

  Affiliations Department of Family Medicine, Clalit Health Services, Sharon-Shomron, Israel, Gray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel

  https://orcid.org/0000-0002-8820-3202

  ⨯
• Yair Levy,

  Roles Supervision

  Affiliations Gray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel, Internal Medicine Department E, Meir Medical Center Research Institute, Clalit Health Services, Kfar Saba, Israel

  ⨯
• Tzipi Hornik-Lurie

  Roles Data curation

  Affiliation Department of Family Medicine, Clalit Health Services, Sharon-Shomron, Israel

  https://orcid.org/0000-0002-2122-5116

  ⨯